Thierry Gil

9.1k citations
94 papers · 3.5k · 2 hit papers · h-index 22

Impact in

    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment
    • Sarcoma Diagnosis and Treatment
    • Renal cell carcinoma treatment
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Prostate Cancer Treatment and Research 21
    • Renal cell carcinoma treatment 8
    • Sarcoma Diagnosis and Treatment 8
    • Cancer Treatment and Pharmacology 14
    • Cancer Immunotherapy and Biomarkers 9

Thierry Gil

92 papers receiving 3.4k citations

Thierry Gil's Hit Papers

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 2011 · 536 citations
5360+9+19Years since publication2505007501000

Peers

Thierry Gil
Comparison fields: 5 of 83
  • Pulmonary and Respiratory Medicine 1.8k
  • Oncology 814
  • Cancer Research 336
  • Surgery 729
  • Hepatology 101
Replace R. Bryan Rumble with:
R. Bryan Rumble United States
Kanishka Sircar United States
Brigitte Laguerre France
Thomas Steuber Germany
Matthew M. Cooney United States
Andrew Weickhardt Australia
Tim Akhurst Australia
Ranee Mehra United States
Michael Siebels Germany
Lisa Sengeløv Denmark
Thierry Gil relative to R. Bryan Rumble United States R. Bryan Rumble's profile →
Citations per field
00.5×1.5×
R. Bryan Rumble · 1×
Citations per year

Countries citing papers authored by Thierry Gil

Since Specialization
Citations

This map shows the geographic impact of Thierry Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Gil more than expected).

Fields of papers citing papers by Thierry Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Gil. The network helps show where Thierry Gil may publish in the future.

Co-authors

The 25 scholars most cited alongside Thierry Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Gil Line = papers co-authored together Thierry Gil links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
Hit paper breakdown →
19971190
2
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Hit paper breakdown →
2011536
3 2005273
4 2011134
5 200994
6 201691
7 201582
8 201373
9 201058
10 201644
11 200841
12 201940
13 200139
14 201338
15
A phase I, clinical and pharmacokinetic (PK) trial of the farnesyl transferase inhibitor (FTI) R115777 + docetaxel : a promising combination in patients (pts) with solid tumors
200135
16 202133
17 200730
18 201628
19 200625
20 200924

About Thierry Gil

Thierry Gil is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 94 papers that have together received 3.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Cancer Treatment and Pharmacology (14 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Renal cell carcinoma treatment (8 papers), Sarcoma Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Oncology (814 citations), Cancer Research (336 citations), Surgery (729 citations) and Hepatology (101 citations). Thierry Gil has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Laurence Collette, Cora N. Sternberg, Padraig Warde, Guy Storme, Abraham Kuten, M. Bolla, Jacques Bernier, Dionisio González, René‐Olivier Mirimanoff and J.B. Dubois. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact